Research

Awareness Week to Shine Spotlight on Antimicrobial Resistance Next Week

November 15, 2024

Antimicrobial resistance (AMR) is a growing, significant One Health issue across the world. The WHO estimates that AMR was directly responsible for 1.27 million global deaths and contributed to 4.95 million deaths, with additional significant economic costs. AMR affects all countries and all income groups, and to tackle this urgent problem, researchers, producers, and practitioners from all areas must address the critical shortage of new antimicrobial drugs, and the use of antimicrobial drugs in medicine, farming, and industry. The week of November 18-24 is US Antibiotic Awareness Week and World AMR Awareness Week, and the College of Veterinary Medicine is taking advantage of these national and global campaigns to raise awareness about AMR and antimicrobial stewardship, and to highlight some of the research and practices being conducted at the college to address AMR.


PVM Faculty Honored for Research Success with Purdue Seed for Success Acorn Awards

November 15, 2024

When Purdue University’s Office of Research honored the accomplishments and innovative ideas of a host of researchers this week, several Purdue Veterinary Medicine scholars were among those recognized. At a ceremony Wednesday, November 14, in the Purdue Memorial Union North and South Ballrooms, the annual Seed for Success Acorn Awards were presented to Purdue Principal Investigators (PIs) and co-PIs who secured research awards of $1 million or more for a single proposal in fiscal year 2024.


Unlocking the Mysteries of the Brain

November 15, 2024

Despite more than six decades of research in the field of neuroscience, many functions of the brain — the most complex organ in the human body — remain a mystery. Recent research conducted in the Purdue University College of Veterinary Medicine and the Bindley Bioscience Center revealed that scientists are one step closer to understanding the process that activates and deactivates specific proteins within our cells. This breakthrough could one day lead to enhanced treatments that may slow down or perhaps reverse the advance of neurogenerative diseases such as Alzheimer’s, Parkinson’s and multiple sclerosis.


Former BMS Professor and GeniPhys Founder Sees Continued Success in Development of Wound Management Product

October 25, 2024

GeniPhys, a preclinical-stage company founded by a Purdue University researcher with ties to the College of Veterinary Medicine, is expected to commercialize a wound management product in the second quarter of 2025 that involves developing regenerative collagen polymeric biomaterials for soft tissue restoration.  Collymer SAS was developed by Sherry Harbin, a Purdue professor of biomedical engineering and former professor (now professor by courtesy appointment) in the College of Veterinary Medicine’s Department of Basic Medical Sciences.


Building on Scholarly Excellence, Veterinary Medicine Postdoc Researcher Pursues Solutions to Global Crisis in Countering Antibiotic Resistance, Superbugs

October 18, 2024

Years of growing resistance to antibiotics have sparked an urgent global health crisis, giving rise to challenging biological threats and the emergence of more dangerous viral, fungal and bacterial strains, commonly called superbugs. Compounding the threat is the difficulty in a quick diagnosis, complicating how to effectively treat these illnesses. Purdue postdoctoral researcher Sharath Iyengar in the College of Veterinary Medicine’s Department of Basic Medical Sciences spends hours in the G221 laboratory at Lynn Hall, seeking answers to this health challenge.


Coppoc One Health Lecture Brings Princeton Scholar to Purdue to address 21st Century Challenges

October 11, 2024

Each year, the Purdue University College of Veterinary Medicine brings a leading One Health scholar to campus to address vital health issues from a One Health perspective that is based on the understanding that human, animal, plant, and environmental health are linked. This year, Princeton scholar Laura Kahn, MD, MPH, MP, will give the annual Coppoc One Health Lecture on the topic, “A One Health Analysis of Food Safety and Security, Antimicrobial Resistance, and Climate Change in the 21st Century.” The presentation at 12:30 p.m. on November 7 in Lynn Hall room 1136 is free and open to the public.


Ugandan Wildlife Veterinarian Captivates Lynn Hall Audience with Message about Conservation of Gorillas

October 4, 2024

The Purdue University College of Veterinary Medicine welcomed an international visitor this week who traveled half-way around the world to share a presentation with veterinary students entitled Conservaton of Gorillas through the One Health Approach. Dr. Gladys Kalema-Zikusoka, from Uganda, was a 2023 finalist for the Indianapolis Prize, which is awarded by the Indianapolis Zoo and is considered the world’s leading animal conservation award.


It’s Here! 2024 Purdue Veterinary Conference Starts Tuesday!

September 13, 2024

Purdue Veterinary Medicine’s signature annual conference for Veterinarians and Veterinary Nurses kicks-off Tuesday, September 17 and continues through Saturday, September 21, with hours of engaging continuing education sessions, special events, keynote presentations, and the annual Dr. Skip Jackson Dog Jog. In total, the conference offers more than 100 sessions, an Exhibit Hall with vendors displaying the latest products, and up to 25 Continuing Education credits. If you missed out on registration, walk-in registration will be available on site.


Innovating Cancer Treatment

August 30, 2024

A husband-wife team of veterinary oncologists with expertise in tumor ablation devices is now part of the Purdue University College of Veterinary Medicine’s Department of Veterinary Clinical Sciences and the Evan and Sue Ann Werling Comparative Oncology Research Center.


Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development

August 16, 2024

Akston Biosciences Corporation, which is dedicated to accelerating the biologics revolution in Animal Health, and Purdue University have announced a strategic partnership to co-develop an anti-cPD-L1 monoclonal antibody (mAb) immunotherapy to treat cancer in dogs. The underlying technology was developed at the Purdue University College of Veterinary Medicine and the Purdue Institute for Cancer Research (PICR).